| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |